FOXR2-activated: Clinical Trials

1 trial for FOXR2-activated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow FOXR2-activated: new trials by email Literature Review of FOXR2-activated trials Research Report on FOXR2-activated

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor
Phase 1RecruitingStanford University182025-08-282026-10-09

Narrower conditions

Brain Neoplasms (1)  ·  Medulloblastoma (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Pinealoma (1)  ·  Rhabdoid Tumor (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neuroectodermal Tumors (1)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Stanford University (1)

Countries

United States (1)

Top investigators

Katherine Ryan, DO (1)